Understanding the underlying metabolic abnormalities of polycystic ovary syndrome and their implications

American Journal of Obstetrics and Gynecology

Volumn 179, Issue 6 II, 1998, Pages

  Taylor, A E ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cardiovascular risk factors; Insulin resistance; Obesity; Polycystic ovary syndrome

Indexed keywords

GLUCOSE; INSULIN;

ARTICLE; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; FEMALE; GLUCOSE INTOLERANCE; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; INSULIN RELEASE; INSULIN RESISTANCE; METABOLIC DISORDER; OBESITY; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR;

EID: 0032407622     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9378(98)70239-x     Document Type: Article

References (65)

1. JK Zawadzki A Dunaif Diagnostic criteria for polycystic ovary syndrome: towards a rational approach A Dunaif JR Givens FP Haseltine GR Merriam Polycystic ovary syndrome 1992 Blackwell Scientific Boston 377
2. I Stein M Leventhal Amenorrhea associated with bilateral polycystic ovaries Am J Obstet Gynecol 29 1935 181 191
3. S Robinson SP Chan S Spacey V Anyaoku DG Johnston S Franks Postprandial thermogenesis is reduced in polycystic ovary syndrome and is associated with increased insulin resistance Clin Endocrinol 36 1992 537 543
4. KR Segal A Dunaif Resting metabolic rate and postprandial thermogenesis in polycystic ovarian syndrome Int J Obes 14 1990 559 567
5. J Vague The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease Am J Clin Nutr 4 1956 20 34
6. M Krotkiewski P Bjorntorp L Sjostrom U Smith Impact of obesity on metabolism in men and women: importance of regional adipose tissue distribution J Clin Invest 72 1983 1150 1162
7. DJ Evans JH Barth CW Burke Body fat topography in women with androgen excess Int J Obes 12 1988 157 162
8. R Pasquali F Casimirri S Cantobelli AM Labate S Venturoli R Paradisi Insulin and androgen relationships with abdominal body fat distribution in women with and without hyperandrogenism Horm Res 39 1993 179 187
9. AJ Hartz DC Rupley AA Rimm The association of girth measurements with disease in 32,856 women Am J Epidemiol 119 1984 71 80
10. SM Haffner D Fong HP Hazuda JA Pugh JK Patterson Hyperinsulinemia, upper body adiposity, and cardiovascular risk factors in non-diabetics Metabolism 37 1988 338 345
11. AH Kissebah N Vydelingum R Murray DJ Evans AJ Hartz RK Kalkhoff Relation of body fat distribution to metabolic complications of obesity J Clin Endocrinol Metab 54 1982 254 260
12. DS Freedman SJ Jacobsen JJ Barboriak KA Sobocinski AJ Anderson AH Kissebah Body fat distribution and male/female differences in lipids and lipoproteins Circulation 81 1990 1498 1506
13. L Lapidus O Helgesson C Merck P Bjorntorp Adipose tissue distribution and female carcinomas: a 12-year follow-up of participants in the population study of women in Gothenburg, Sweden Int J Obes 12 1988 361 368
14. DV Schapira NB Kumar GH Lyman CE Cox Abdominal obesity and breast cancer risk Ann Intern Med 112 1990 182 186
15. TA Sellers LH Kushi JD Potter SA Kaye CL Nelson PG McGovern Effect of family history, body-fat distribution, and reproductive factors on the risk of postmenopausal breast cancer N Engl J Med 326 1992 1323 1329
16. DV Schapira NB Kumar GH Lyman D Cavanagh WS Roberts J LaPolla Upper-body fat distribution and endometrial cancer risk JAMA 266 1991 1808 1811
17. L Lapidus C Bengtsson B Larsson K Pennert E Rybo L Sjostrom Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden Br Med J (Clin Res Ed) 289 1984 1257 1261
18. AR Folsom SA Kaye TA Sellers CP Hong JR Cerhan JD Potter Body fat distribution and 5-year risk of death in older women JAMA 269 1993 483 487
19. C Achard J Thiers Le virilisme pilaire et son association à l’insuffisance glycolytique (diabete des femmes à barbe) Bull Acad Natl Med (Paris) 86 1921 51 64
20. CR Kahn JS Flier RS Bar JA Archer P Gorden MM Martin The syndromes of insulin resistance and acanthosis nigricans: insulin receptor disorders in man N Engl J Med 294 1976 739 745
21. GA Burghen JR Givens AE Kitabchi Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease J Clin Endocrinol Metab 50 1980 113 116
22. RJ Chang RM Nakamura HL Judd SA Kaplan Insulin resistance in nonobese patients with polycystic ovary syndrome J Clin Endocrinol Metab 57 1983 356 359
23. A Dunaif KR Segal W Futterweit A Dobrjansky Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome Diabetes 38 1989 1165 1174
24. N Tarlin D Finegood G Green D Shelley A Dunaif Use of the minimal model to determine insulin action in an insulin resistant population [abstract] Endocr Soc 786 1992 227
25. MF Saad RL Anderson A Laws RM Watanabe WW Kades YD Chen A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance Diabetes 43 1994 1114 1121
26. J Holte T Bergh C Berne L Berglund H Lithell Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance J Clin Endocrinol Metab 78 1994 1052 1058
27. DA Ehrmann J Sturis MM Byrne T Karrison RL Rosenfield KS Polonsky Insulin secretory defects in polycystic ovary syndrome: relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus J Clin Immunol 96 1995 520 527
28. J Holte T Bergh C Berne L Wide H Lithell Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome J Clin Endocrinol Metab 80 1995 2586 2593
29. XJ Sun M Miralpeix MG Myers Jr EM Glasheen JM Backer CR Kahn Expression and function of IRS-1 in insulin signal transduction J Biol Chem 267 1992 22662 22672
30. A Dunaif Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non–insulin-dependent diabetes mellitus Am J Med 98 suppl 1A 1995 33S 39S
31. LR Sorbara Z Tan A Cama J Xia E Schenker RA Kohanski Absence of insulin receptor gene mutations in three insulin-resistant women with the polycystic ovary syndrome Metabolism 43 1994 1568 1574
32. JA Talbot EJ Bicknell M Rajkhowa A Krook S O’Rahilly RN Clayton Molecular scanning of the insulin receptor gene in women with polycystic ovarian syndrome J Clin Endocrinol Metab 81 1996 1979 1983
33. TP Ciaraldi A El-Roeiy Z Madar D Reichart JM Olefsky SS Yen Cellular mechanisms of insulin resistance in polycystic ovarian syndrome J Clin Endocrinol Metab 75 1992 577 583
34. A Dunaif KR Segal DR Shelley G Green A Dobrjansky T Licholai Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome Diabetes 41 1992 1257 1266
35. A Dunaif J Xia CB Book E Schenker Z Tang Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle: a potential mechanism for insulin resistance in the polycystic ovary syndrome J Clin Invest 96 1995 801 810
36. S Takayama MF White CR Kahn Phorbol ester–induced serine phosphorylation of the insulin receptor decreases its tyrosine kinase activity J Biol Chem 263 1988 3440 3447
37. A Dunaif M Graf J Mandeli V Laumas A Dobrjansky Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia J Clin Endocrinol Metab 65 1987 499 507
38. RS Legro WC Dodson A Dunaif PCOS: a reservoir of reproductive age glucose intolerance poorly detected by fasting blood glucose levels [abstract OR41-3] Proceedings of the Endocrine Society 80th Annual Meeting, New Orleans, La June 24-28, 1998
39. MI Harris WC Hadden WC Knowler PH Bennett Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in US population aged 20-74 yr Diabetes 36 1987 523 534
40. E Dahlgren S Johansson G Lindstedt F Knutsson A Oden PO Janson Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones Fertil Steril 57 1992 505 513
41. J Holte G Gennarelli L Wide H Lithell C Berne High prevalence of polycystic ovaries and associated clinical, endocrine and metabolic features in women with previous gestational diabetes J Clin Endocrinol Metab 83 1998 1143 1150
42. I Zavaroni E Bonora M Pagliara E Dall-Aglio L Luchetti G Guonanno Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance N Engl J Med 320 1989 702 706
43. RA Wild PC Painter PB Coulson KB Carruth GB Ranney Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome J Clin Endocrinol Metab 61 1985 946 951
44. MJ Graf CJ Richards V Brown L Meissner A Dunaif The independent effects of hyperandrogenaemia, hyperinsulinaemia, and obesity on lipid and lipoprotein profiles in women Clin Endocrinol 33 1990 119 131
45. S Zimmerman RA Phillips A Dunaif DT Finegood C Winkenfeld M Ardeljan Polycystic ovary syndrome: lack of hypertension despite profound insulin resistance J Clin Endocrinol Metab 75 1992 508 513
46. RA Wild B Grubb A Hartz JJ Van Nort W Bachman M Bartholomew Clinical signs of androgen excess as risk factors for coronary artery disease Fertil Steril 54 1990 255 259
47. MA Birdsall CM Farquhar HD White Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterizaiton Ann Intern Med 126 1997 32 35
48. DS Guzick EO Talbott K Sutton-Tyrrell HC Herzog LH Kuller SK Wolfson Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study Am J Obstet Gynecol 174 1996 1224 1232
49. RL Barbieri S Smith KJ Ryan The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism Fertil Steril 50 1988 197 212
50. RL Barbieri A Makris KJ Ryan Insulin stimulates androgen accumulation in incubations of human ovarian stroma and theca Obstet Gynecol 64 suppl 1984 73S 80S
51. D Willis H Mason C Gilling-Smith S Franks Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries J Clin Endocrinol Metab 81 1996 302 309
52. ER Hernandez A Hurwitz A Vera A Pellicer EY Adashi D Le Roith Expression of the genes encoding the insulin-like growth factors and their receptors in the human ovary J Clin Endocrinol Metab 74 1992 419 425
53. SR Plymate LA Matej RE Jones KE Friedl Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin J Clin Endocrinol Metab 67 1988 460 464
54. JE Nestler LP Powers DW Matt KA Steingold SR Plymate RS Rittmaster A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with polycystic ovary syndrome J Clin Endocrinol Metab 72 1991 83 89
55. DS Kiddy D Hamilton-Fairley M Seppala R Koistinen VH James MJ Reed Diet-induced changes in sex hormone binding globulin and free testosterone in women with normal or polycystic ovaries: correlation with serum insulin and insulin-like growth factor-1 Clin Endocrinol 31 1989 757 763
56. P Moghetti R Castello C Negri F Tosi GG Spiazzi E Brun Insulin infusion amplifies 17-alpha-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: apparent relative impairment of 17,20 lyase activity J Clin Endocrinol Metab 81 1996 881 886
57. S Robinson D Kiddy SV Gelding D Willis R Niththyananthan A Bush The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries Clin Endocrinol 39 1993 351 355
58. JE Nestler DJ Jakubowicz Decreases in ovarian cytochrome P450c17 activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome N Engl J Med 335 1996 617 623
59. EM Velazquez S Mendoza T Hamer F Sosa CJ Glueck Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy Metabolism 43 1994 647 654
60. PW Speiser J Serrat MI New JM Gertner Insulin insensitivity in adrenal hyperplasia due to nonclassical steroid 21-hydroxylase deficiency J Clin Endocrinol Metab 75 1992 1421 1424
61. A Dunaif G Green W Futterweit A Dobrjansky Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary J Clin Endocrinol Metab 70 1990 699 704
62. KE Elkind-Hirsch CT Valdes LR Malinak Insulin resistance improves in hyperandrogenic women treated with Lupron Fertil Steril 60 1993 634 641
63. P Moghetti F Tosi R Castello CM Magnani C Negri E Brun The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women J Clin Endocrinol Metab 81 1996 952 960
64. R Pasquali D Antenucci F Casimirri S Venturoli R Paradisi F Fabbri Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss J Clin Endocrinol Metab 68 1989 173 179
65. X-R Pan G-W Li Y-H Hu J-X Wang Z-X An Juan-Lin Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and diabetes study Diabetes Care 20 1997 537 544